UNSPSC 85704703: Revision of autologous tissue substitute in left patella, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of autologous tissue substitute in left patella, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0QWF37Z

UNSPSC 85704703 Revision of autologous tissue substitute in left patella, percutaneous approach (Commodity) shows little relevant recent activity in state and local procurement. The code's nominal scope describes a specific orthopedic surgical procedure, yet the recent opportunities posted under it—disability medical evaluations for pension systems, surgical benefit carve-outs for employee health plans, occupational medical surveillance, specialty and emergency medical services for youth in custody, pharmacy benefit management, and temporary health professional staffing—do not align with procurement of autologous tissue substitutes or orthopedic surgical revision services. The mismatch suggests either a tagging error in how issuing bodies have classified these opportunities or a fundamental divergence between the code's technical definition and current state and local buying practice under this code number.

The geographic spread of the opportunities spans Arizona (City of Phoenix), California (City of Long Beach and County of Santa Clara), Washington (Washington State Department of Transportation), and Texas (Harris County), with response dates ranging from September through October 2026. The issuing bodies include municipal retirement offices, cities, a state transportation agency, a county juvenile probation department, a county health system, and county human resources divisions—a broad cross-section of local government. Without evidence of state and local procurement actually soliciting autologous tissue substitutes or orthopedic procedures under this code, and given the scope mismatch, this code does not present clear near-term opportunity for vendors in orthopedic implants, surgical tissues, or related medical device categories.